Inhaled corticosteroids and COVID-19: a systematic review and clinical perspective

Eur Respir J. 2020 May 7;55(5):2001009. doi: 10.1183/13993003.01009-2020. Print 2020 May.

Abstract

There is no evidence on benefits or harms of inhaled steroids in COVID-19. It is essential that epidemiological studies of COVID-19 include detailed information on comorbidities and prior medication to help answer this question. https://bit.ly/2XVwIsa

Publication types

  • Editorial
  • Systematic Review

MeSH terms

  • Administration, Inhalation
  • Adrenal Cortex Hormones / administration & dosage*
  • Betacoronavirus
  • COVID-19
  • Coronavirus Infections / diagnosis
  • Coronavirus Infections / drug therapy*
  • Coronavirus Infections / epidemiology
  • Coronavirus*
  • Dyspnea / etiology
  • Humans
  • Pandemics*
  • Pneumonia, Viral / diagnosis
  • Pneumonia, Viral / drug therapy*
  • Pneumonia, Viral / epidemiology
  • SARS-CoV-2

Substances

  • Adrenal Cortex Hormones

Supplementary concepts

  • COVID-19 drug treatment